Skip to main content

Table 2 Biochemical indicators of patients with ACI and with and without PSD

From: Predictors of early-onset post-ischemic stroke depression: a cross-sectional study

Variables, mean(SD)

PSD (n = 36)

Non-PSD (n = 47)

P value

TT3, μg/L

1.1(0.2)

1.3(0.2)

< 0.001#

TT4, μg/L

79.8(10.6)

81.1(11.0)

0.587

TSH, uIU/mL

1.6(0.9)

1.5(0.7)

0.629

LDL, mmol/L

2.5(0.9)

2.6(0.9)

0.622

HDL, mmol/L

1.2(0.3)

1.2(0.4)

0.549

FBG, mmol/L

6.8(2.2)

6.3(2.0)

0.338

2hPBG, mmol/L

10.2(4.6)

9.6(4.5)

0.548

HbAlc, %

6.1(1.5)

6.2(1.8)

0.793

NE, ng/L

931.8(172.9)

1237.8(296.5)

< 0.001#

DA, ng/L

46.7(10.2)

64.7(8.9)

< 0.001#

5-HT, ng/L

821.7(228.4)

1065.9(144.3)

< 0.001#

IL-6, ng/L

4.6(1.0)

3.4(0.9)

< 0.001#

TNF-α, ng/L

224.4(44.1)

164.9(43.7)

< 0.001#

NGF, ng/L

6.5(1.5)

8.1(1.6)

< 0.001#

CGRP, pg/ml

41.9(6.1)

38.3(13.8)

0.112

  1. P values compare persons with and without PSD. # P < 0.001 vs non-PSD group
  2. Data are displayed as mean (standard deviation)
  3. CGRP calcitonin gene-related peptide, DA dopamine, FBG fasting blood glucose, 5-HT 5-hydroxytryptamine, HbA1c glycosylated hemoglobin, type A1c, HDL high-density lipoprotein, IL-6 interleukin 6, LDL low-density lipoprotein, NE norepinephrine, NGF nerve growth factor, 2hPBG 2-h postprandial blood glucose, PSD post-stroke depression, SD standard deviation, TNF-α tumor necrosis factor-α, TSH thyroid-stimulating hormone, TT3 total triiodothyronine, TT4 total thyroxine